Genpact CFO granted 35,396 RSUs in share award

Genpact Limited’s Chief Financial Officer Michael Hal Weiner received an equity award of 35,396 common shares on January 30, 2026.

Rhea-AI Filing Summary

Genpact Limited’s Chief Financial Officer Michael Hal Weiner received an equity award of 35,396 common shares on January 30, 2026. The award was granted at a price of $0 per share in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one common share upon vesting. One-third of the shares are scheduled to vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, conditioned on his continued service. Following this grant, he beneficially owned 171,471 common shares in total.

Insider Trade Summary

Grant/Award: 35,396 shares

Grant/Award 1 txn

Insider Weiner Michael Hal

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	35,396	$0.00	$0.00

Holdings After Transaction: Common Shares — 171,471 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

What insider transaction did Genpact (G) disclose for its CFO?

Genpact disclosed that CFO Michael Hal Weiner received an award of 35,396 restricted share units on January 30, 2026. The RSUs were granted at $0 per share and increase his beneficial ownership to 171,471 common shares after the transaction.

How many Genpact (G) shares did the CFO hold after this Form 4 transaction?

After the reported transaction, CFO Michael Hal Weiner beneficially owned 171,471 Genpact common shares. This total includes the 35,396 restricted share units granted on January 30, 2026, each of which is convertible into one common share upon vesting.

What are the vesting terms of the CFO’s RSU grant at Genpact (G)?

The 35,396 restricted share units granted to Genpact’s CFO vest in three equal installments. One-third vests on January 10, 2027, another third on January 10, 2028 and the final third on January 10, 2029, contingent on his continued service.

Is the Genpact (G) CFO’s Form 4 transaction a purchase or an award?

The transaction is an equity award, not an open-market purchase. CFO Michael Hal Weiner received 35,396 restricted share units at a price of $0 per share under Genpact Limited’s 2017 Omnibus Incentive Compensation Plan, subject to multi-year vesting.

What type of security did the Genpact (G) CFO receive in this filing?

The CFO received restricted share units linked to Genpact common shares. Each RSU entitles him to one common share upon vesting, with a total of 35,396 RSUs granted and vesting scheduled annually from January 10, 2027 through January 10, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiner Michael Hal

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		35,396(1)	A	$0	171,471	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Michael Hal Weiner	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.